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Abstract 13 
Human papillomavirus (HPV) vaccines are currently utilised globally in national 14 
immunisation programmes. Many new European migrants have settled in the United 15 
Kingdom (UK) since the 2004 European Union expansion with approximately 91,000 Polish 16 
people resident in Scotland. Following anecdotal reports from several NHS Boards within 17 
Scotland of lower HPV vaccine uptake in Polish communities compared with other ethnic 18 
minorities, an extract containing both forename and surname, was taken from the Scottish 19 
Immunisation Recall System (SIRS) for all girls in S2 and S3 in school years 2014/15 to 20 
2016/17. We then used the OnoMap algorithm software to derive ethnicity. OnoMap 21 
identified between 289 and 321 age-eligible girls as Polish with significant disparity noted for 22 
completed HPV vaccine uptake between UK (87.2-89.8%) and Polish ethnicities (69.7-23 
77.2%) (P<0.01). Preliminary discussions with Polish families suggest that vaccine 24 
programme differences, trust in medical/healthcare practitioners, and cultural influences may 25 
be important drivers of acceptance.  26 
Introduction 27 
In Scotland, since 2008, school-based uptake of both the bivalent and quadrivalent HPV 28 
vaccines in girls aged 12–13 has been impressive, with vaccine uptake sustained at levels 29 
exceeding 90% (Sinka et al. 2014). Implementation of the programme began as soon as the 30 
school session started in August 2008 following an extensive communication campaign with 31 
eye-catching, age-appropriate TV, radio and news coverage over the summer holidays. 32 
Nearly all HPV vaccines for this age cohort in Scotland are offered in the school setting. 33 
Despite recent communications to head teachers and school nurses from anti-HPV vaccine 34 
groups in the UK, those involved in the programme remain committed to ensuring high 35 
uptake of the vaccine continues. Although the vaccine programme has been successful within 36 
the UK, the Republic of Ireland has observed considerable disparities in school uptake 37 
associated with socioeconomic disadvantage (Migone et al., 2017). Furthermore, while 38 
parental intent and knowledge of the HPV vaccines has increased over time, lack of 39 
perceived importance of HPV vaccination and parental concerns about vaccine safety remain 40 
barriers to both HPV vaccination series initiation and completion, especially in the USA 41 
(Hanson et al. 2018). 42 
Many new European migrants have settled in the United Kingdom since the 2004 European 43 
Union expansion with approximately 91,000 Polish people now resident in Scotland 44 
(National Records of Scotland, 2017). Following anecdotal reports from several of Scotland’s 45 
14 regional NHS Boards of lower HPV vaccine uptake in Polish communities, we aimed to 46 
formally assess uptake of HPV vaccine in Polish girls through ethnicity analysis at the 47 
national level.    48 
Methods 49 
An extract, containing both forename and surname, was taken from SIRS, for all girls in S3 50 
in the school years 2014/15 to 2016/17. S3 is the third year of secondary school in Scotland 51 
(year 10 in England) and girls are aged 13-14. These extracts were then fed through OnoMap 52 
Name Classification software to derive ethnicity (Onomap; Publicprofiler Ltd, UK). Onomap 53 
offers an effective methodology for identifying population groups in both health-related and 54 
educational datasets, categorizing populations into a variety of ethnic groups. Previous 55 
evaluations have suggested that it can successfully assist health researchers, planners and 56 
policy makers in identifying and addressing health inequalities (Lakha et al. 2011). The 57 
surname and forename recorded in the SIRS database for each person were matched to an 58 
Onomap subgroup, which is the lowest level in the Onomap classification system. 59 
Furthermore, as a sense check, one of the Polish speaking authors assessed forename/surname 60 
composition in the SIRS extract, confirming that Onomap was an appropriate tool for 61 
estimation of ethnicity. Ethnicity was categorised into UK, Eastern European, and Polish. 62 
The cohort data was based on girls registered in S3 in Scotland on Child Health Schools 63 
Programme-School (CHSP-S) as at mid-May of the relevant school year. The vaccination 64 
data by ethnicity was based on the SIRS extract as at mid-August following the end of each 65 
school year. The published Scotland totals refer to uptake rates reported for the S3 cohort at 66 
the time the data for each school year were first published as national statistics. A completed 67 
course of HPV in 2014/15 was three doses of HPV, while in 2015/16 and 2016/17 it was two 68 
doses (Chief Medical Officer for Scotland, 2014). Ethical approval was obtained from the 69 
Public Health Intelligence Information Governance committee and approved by the relevant 70 
Caldicott Guardian.  71 
Results 72 
The majority of girls in S3 in each of the three annual cohorts were classed as British Isles, 73 
ranging from 90.2% to 91.8%.  The percentage of S3 girls who were identified as Eastern 74 
Europe ranged from 1.4% to 1.6%. Approximately 75% of those identified as Eastern 75 
European were identified as Polish (Table 1).  76 
Uptake in Eastern European and Polish S3 girls (range 68.1-75.5%; 69.7-79.2%) was 77 
significantly lower than in girls categorised as UK (87.2-89.6%) (P<0.01). The trend in 78 
uptake across the three years was similar for the three different, with uptake falling in 79 
2015/16 then increasing in 2016/17. The decrease in uptake in 2015/16 was larger among 80 
girls classed as Eastern European and the Polish sub-group, compared with UK girls. 81 
Although uptake rates rebounded in 2016/17 among all three groups, it was only the uptake 82 
among UK girls that recovered to the level observed in 2014/15 (Table 1). 83 
  84 
Table 1. Uptake of completed course of HPV by S3 by Ethnic Groups and Academic 85 
Year. 86 
School 
Year Ethnicity S3 Cohort 
Completed HPV 
95% CI n % 
2014/15 
UK 24,377 21,840 89.6 (89.2-90.0) 
Eastern Europe 376 284 75.5 (70.9-79.6) 
Polish 289 223 77.2 (72.0-81.6) 
Published Scotland 
Total 
26,554 23,588 88.8 
  
2015/16 
UK 23,816 20,775 87.2 (86.8-87.6) 
Eastern Europe 382 260 68.1 (63.2-72.5) 
Polish 300 209 69.7 (64.2-74.6) 
Published Scotland 
Total 
26,104 22,570 86.5 
  
2016/17 
UK 23,389 20,998 89.8 (89.4-90.2) 
Eastern Europe 418 304 72.7 (68.3-76.8) 
Polish 321 231 72.0 (66.8-76.6) 
Published Scotland 
Total 
25,932 23,040 88.8 
  
 87 
  88 
Discussion 89 
In this study, we confirmed a significant disparity in HPV vaccine uptake amongst Eastern 90 
European and Polish communities within Scotland, a country with high uptake since 91 
programme inception. This phenomenon appears to be uniquely associated with Polish and 92 
Eastern European communities, since uptake of the HPV vaccine in girls from the Indian sub-93 
continent was comparable (86% for two doses) to those identified as being UK born. Within 94 
the EU, Poland is one of eight countries where HPV vaccination is yet to have been made 95 
part of a free-of-charge mandatory form of immunisation programme (Ganczak et al. 2018). 96 
Consequently, HPV vaccination coverage in adolescent Polish girls is estimated at 1.5–10%. 97 
This is much lower than those reported in countries where the cost of vaccinations is covered 98 
from the national budget. Poland has recognised issues with vaccine hesitancy and an active 99 
anti-vaccination movement (Braczkowska et al., 2017; Jaroszewska et al., 2014). 100 
However, notwithstanding that, the recent study by Ganczak and colleagues demonstrated 101 
that attitudes regarding their child being vaccinated against HPV were generally positive 102 
among Polish parents, even though awareness and knowledge of HPV in this group were low. 103 
If a girl wants vaccination the vaccine must be purchased by the parents and administered 104 
through primary health care or outpatient clinic. Most of the significant factors that 105 
influenced their willingness were modifiable, such as being informed about HPV and having 106 
positive attitudes toward vaccines.  107 
These findings have important implications for the trans-national study of vaccine uptake and 108 
the drivers of these, especially in countries that experience significant immigration. The main 109 
aim of characterizing the nature and scale of vaccine acceptance issues is to appropriately 110 
inform the development of strategies and policies to address the concerns expressed, while 111 
sustaining confidence in vaccination (Larson et al. 2015). Reducing inequalities is also a key 112 
aim of generating and maintaining equitable uptake of vaccines, and where cervical cancer 113 
disproportionately affects the most deprived, it is even more important to ensure uptake of the 114 
HPV vaccine is evenly distributed across national populations. 115 
One of the main limitations of our study was the reliance on the Onomap naming algorithm to 116 
accurately identify ethnicity. The utility of Onomap has been validated in several studies 117 
(Smith et al. 2017). Combining ethnicity from multiple sources results in a more complete 118 
estimate of ethnicity than the use of one single source but we believe that this does not 119 
significantly affect the main findings of this study. The phenomenon of decreased vaccine 120 
uptake is prevalent in the Polish communities within Scotland, as is demonstrated in another 121 
study that was performed simultaneously for childhood influenza vaccine (Bielecki et al. 122 
2018 – manuscript submitted to Vaccine). This study only involved administrative uptake 123 
data and not parent interviews. Consequently, this study was unable to discern the actual 124 
reasons behind the lower HPV uptake among Polish girls and was not able to identify 125 
whether, and to what extent, parents were reluctant or concerned about HPV vaccination. 126 
Despite higher rates of HPV vaccine uptake compared to those residents in Poland, this study 127 
demonstrates significantly lower rates of HPV vaccine uptake in girls of Polish and Eastern 128 
European ethnicity compared to others in Scotland. We have conducted an explorative 129 
qualitative study with Polish families, which suggest that vaccine programme differences 130 
between Poland and the UK, trust in medical/healthcare practitioners, and cultural influences 131 
may be important drivers of acceptance. Furthermore, this qualitative study has revealed that 132 
Polish women expressed fears in relation to the side-effects of the HPV vaccine, an 133 
independent predictor of parental willingness to have their child vaccinated (Ganczak et al. 134 
2018). Strategies to promote uptake of HPV vaccines amongst Polish and Eastern European 135 
communities should be promoted, especially given poor uptake of cervical screening in these 136 
communities (Mazdziarz et al., 2017).137 
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